LBX2 and colorectal carcinoma: In different clinicopathological groups, LBX2 could identify LNM of CRC well in both ulcerated and non-ulcerated groups, both lymphatic and non- lymphatic invasion groups, both vascular and non-vascular invasion groups, and both neural and non-neural invasion groups (P < 0.001) (Figures 4E-H).